Flumatinib (HHGV678) is an orally available, selective inhibitor of Bcr-Abl. Flumatinib inhibits c-Abl, PDGFRbeta and c-Kit with IC50s of 1.2 nM, 307.6 nM and 665.5 nM, respectively[1].
Molecular Weight:
562.59
Purity:
99.94
CAS Number:
[895519-90-1]
Formula:
C29H29F3N8O
Target:
Bcr-Abl,c-Kit,PDGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
